The DSO Rebound: Why 2026 Is the Most Active Dental M&A Year Since 2022
Dental M&A has rebounded strongly in 2026 after a slowdown driven by elevated capital costs, enhanced due diligence, and unrealistic seller valuations. DSOs are aggressively expanding across specialties — from pediatrics to orthodontics — backed by private equity and strategic investors, with 69% of DSOs surveyed reporting their PE sponsors expect a moderate or significant increase in acquisitions this year. Multiple drivers are converging: 60% of practices reported higher top-line revenue in 2024, an aging dentist population (40%+ of dentists are 55 or older in several states), and rising patient demand. The market is currently high-demand, low-supply, pushing DSOs to apply more scrutiny to deal quality and practice performance metrics. Regulatory headwinds persist — California recently expanded the attorney general’s authority over PE entities operating in dental markets.
PE-backed dental platforms competing for acquisitions in 2026 face a tighter deal environment with less margin for error on valuation. Groups that pair selective acquisition discipline with strong pre-acquisition performance metrics — and monitor emerging state-level regulatory risk — will be best positioned in the current cycle.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.